Cerebellar ataxias are a group of genetic and non-genetic disorders that currently have no effective treatment. Despite their different causes, all forms of ataxia share a common set of motor ...

As the only approved treatment to address disease progression, SKYCLARYS addresses a long-standing gap in the care of Canadians living with Friedreich's ataxia Friedreich's ...

Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

Health Canada has granted approval for Biogen’s Skyclarys to treat Friedreich’s ataxia (FA) in individuals aged 16 years and ...

Eleven foals in the Pacific Northwest were diagnosed with a condition called Equine Juvenile Spinocerebellar Ataxia (EJSCA).

At this point, there are several therapies which are coming along, a large trial called the ExRx trial, which included the nutraceutical, nicotinamide riboside has finished. The data are not yet ...

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

We are pleased to share further regulatory clarity for LX2006 for the treatment of Friedreich ataxia cardiomyopathy, and we appreciate the ...